EVOKE PHARMA INC's ticker is EVOK and the CUSIP is 30049G104. A total of 23 filers reported holding EVOKE PHARMA INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $3,000 | 0.0% | 1,285 | 0.0% | 0.00% | – |
| Q3 2016 | $3,000 | -40.0% | 1,285 | +76.5% | 0.00% | – |
| Q2 2016 | $5,000 | +150.0% | 728 | +48.9% | 0.00% | – |
| Q1 2016 | $2,000 | 0.0% | 489 | 0.0% | 0.00% | – |
| Q4 2015 | $2,000 | +100.0% | 489 | 0.0% | 0.00% | – |
| Q3 2015 | $1,000 | -66.7% | 489 | 0.0% | 0.00% | – |
| Q2 2015 | $3,000 | 0.0% | 489 | 0.0% | 0.00% | – |
| Q1 2015 | $3,000 | 0.0% | 489 | 0.0% | 0.00% | – |
| Q4 2014 | $3,000 | 0.0% | 489 | 0.0% | 0.00% | – |
| Q3 2014 | $3,000 | -25.0% | 489 | 0.0% | 0.00% | – |
| Q2 2014 | $4,000 | – | 489 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AIGH Capital Management LLC | 1,433,113 | $2,623,000 | 0.55% |
| Worth Venture Partners, LLC | 336,516 | $616,000 | 0.30% |
| Wambolt & Associates, LLC | 32,000 | $59,000 | 0.03% |
| Pure Financial Advisors, LLC | 17,647 | $32,000 | 0.00% |
| OGOREK ANTHONY JOSEPH /NY/ /ADV | 3,540 | $6,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 179 | $0 | 0.00% |
| NORTHERN TRUST CORP | 42,121 | $77,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 16,101 | $29,000 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 159,979 | $292,000 | 0.00% |